It was suggested that at least in breast cancer cells, such depletions are in part due to the ER-stress mediated activation of ASNS (asparagine synthetase), which depletes aspartate and diminishes aspartate-malate shuttle, negatively impacting TCA [17]. The gene discussed is ASNS; the disease is breast carcinoma.